Capella Healthcare, Inc. Announces First Quarter 2013 Results
May 3, 2013FOR IMMEDIATE RELEASE
Franklin, Tennessee. May 3, 2013 – Capella Healthcare, Inc. (“Capella”) today announced results for the three months ended March 31, 2013.
For the three months ended March 31, 2013, revenue was $187.2 million, compared to $196.9 million for the three months ended March 31, 2012. Adjusted EBITDA for the three months ended March 31, 2013 totaled $21.1 million, compared to $31.8 million for the three months ended March 31, 2012.
Capella’s results for the three months ended March 31, 2012 included adjustments to revenue related to the industry-wide rural floor settlement and the state of Oklahoma’s Supplemental Hospital Offset Payment Program (“SHOPP”). Capella recorded revenue and expenses related to these items of $13.6 and $5.1 million, respectively, during the three months ended March 31, 2012. If the impact of these items is excluded from our results of operations for the three months ended March 31, 2012, revenue and Adjusted EBITDA for the three months ended March 31, 2013 increased $3.9 million and decreased $2.2 million, respectively, compared to the prior year period.
For the three months ended March 31, 2013, admissions and adjusted admissions decreased 1.0% and 1.5% respectively, compared to the prior year period. Adjusting for the impact of an extra day in the prior year period, admissions increased 0.1% and adjusted admissions decreased 0.4%. Revenue per adjusted admission decreased 3.5%, compared to the prior year period. Excluding the prior year period impact of the rural floor settlement and SHOPP, revenue per adjusted admission for the three months ended March 31, 2013 increased 3.7% compared to the prior year period.
“Our first quarter results reflect solid progress on our strategic initiatives in spite of the continued significant challenges that our industry is facing,” said Dan Slipkovich, Chairman and Chief Executive Officer. “Our hospital leadership is doing an excellent job as they continue to improve quality, enhance constituency satisfaction and manage costs. We appreciate the dedicated service provided by physicians, nurses and other health care professionals who work at our family of hospitals.”
About Capella Healthcare
Based in Franklin, Tennessee, Capella Healthcare owns and/or operates general acute-care hospitals in six states. With the philosophy that all health care is local, Capella collaborates with each hospital’s medical staff, board and community leadership to take care to the next level. Capella has access to significant leadership and financial resources, reinvesting in its family of hospitals to strengthen and expand services and facilities. For more information visit the website.
Conference Call
Capella will host a conference call for investors at 9:00 a.m. Central time today. All interested investors are invited to access the call by dialing: 877-806-6964, passcode: 53229352. A replay of the call will be available for a period of 30 days, beginning approximately one hour after the call has concluded. Instructions to access the audio recording can be found on the Investor Relations section of the Company’s website at www.CapellaHealth.com. A copy of the Company’s Form 10-Q for the three months ended March 31, 2013 may be obtained via the Company’s website when filed with the Securities and Exchange Commission.
Cautionary Statement about Preliminary Results and other Forward-Looking Information
This press release contains forward-looking statements based on current management expectations. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those expressed in any forward-looking statements. These factors include, but are not limited to, (1) the impact of healthcare reform and other changes in government programs; (2) spending cuts resulting from the Budget Control Act of 2011; (3) the impact of the economy; (4) growth of uninsured and “patient due” accounts and a deterioration in the collectability of these accounts; (5) federal or state programs that reduce our Medicare or Medicaid payments; (6) the reduction or elimination of payments from third-party payors or the inability to negotiate contracts or maintain satisfactory relationships with third-party payors; (7) controls designed to reduce inpatient services may reduce our revenue; (8) any shortage of qualified professional and staff personnel; (9) our ability to recruit and retain quality physicians; (10) the loss of the services of one or more of our senior management team; (11) our ability to comply with extensive laws and government regulations, including fraud and abuse laws; (12) competition from other hospitals or healthcare providers, including physicians; (13) concentration of revenue in a small number of states, which makes us particularly sensitive to regulatory and economic changes in those states; (14) our access to licensed information systems andthe ability to integrate changes to our existing information systems or information systems of acquired hospitals; (15) liabilities for professional liability and other claims brought against our facilities; (16) potential legal and reputational risk as a result of our access to personal information of our patients; (17) state efforts to regulate the construction or expansion of healthcare facilities; (18) the industry trend toward value-based purchasing; (19) our substantial indebtedness and ability to generate cash flow to service or refinance our indebtedness; and (20) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2012 to be filed with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Capella Healthcare, Inc.
Condensed Consolidated Statements of Operations (Unaudited)
(Dollars in millions)
Capella Healthcare, Inc.
Condensed Consolidated Balance Sheets
(Dollars in millions)
Capella Healthcare, Inc.
Condensed Consolidated Statements of Cash Flows (Unaudited)
(Dollars in millions)
Capella Healthcare, Inc.
Supplemental Non-GAAP Disclosures
Adjusted EBITDA – Reported (Unaudited)
(Dollars in millions)
(1) Adjusted EBITDA is defined as income (loss) before interest expense, income taxes, depreciation and amortization, non-controlling interests, acquisition-related expenses, stock-based compensation, management fee to related party and discontinued operations, net of taxes. Adjusted EBITDA is not intended as a substitute for net income (loss) attributable to Capella Healthcare, Inc. stockholders, operating cash flows or other cash flow data determined in accordance with accounting principles generally accepted in the United States. Due to varying methods of calculation, Adjusted EBITDA as presented may not be comparable to similarly titled measures of other companies.
Capella Healthcare, Inc.
Supplemental Non-GAAP Disclosures
Condensed Consolidated Statements of Operations (Unaudited)
Excluding the impact of the rural floor settlement and prior
year SHOPP on the three months ended March 31, 2012
(Dollars in millions)
(1) Excludes approximately $13.6 million and $5.1 million of revenue and expenses, respectively, for the three months ended March 31, 2013 related to the industry wide rural floor settlement and the prior year out of period SHOPP.
Capella Healthcare, Inc.
Supplemental Non-GAAP Disclosures
Adjusted EBITDA (Unaudited)
Excluding the impact of the rural floor settlement and prior
year SHOPP on the three months ended March 31, 2012
(Dollars in millions)
(1) For the three months ended March 31, 2012, net loss attributable to Capella Healthcare, Inc. excludes the impact of approximately $13.6 million and $5.1 million of revenue and expenses, respectively, related to the industry wide rural floor settlement and the prior year out of period SHOPP.
(2) Adjusted EBITDA is defined as income (loss) before interest expense, income taxes, depreciation and amortization, non-controlling interests, acquisition-related expenses, stock-based compensation, management fee to related party and discontinued operations, net of taxes. Adjusted EBITDA is not intended as a substitute for net income (loss) attributable to Capella Healthcare, Inc. stockholders, operating cash flows or other cash flow data determined in accordance with accounting principles generally accepted in the United States. Due to varying methods of calculation, Adjusted EBITDA as presented may not be comparable to similarly titled measures of other companies.
Capella Healthcare, Inc.
Operating Statistics (1) (Unaudited)
(1) All hospital statistics are on a continuing operations basis and excludes all facilities classified under discontinued operations.